A Phase 1 Dose Escalation Study of VX-973 in Healthy Participants

NCT06615570 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain

Interventions

DRUG: VX-973
DRUG: Placebo

Sponsor

Vertex Pharmaceuticals Incorporated